UNMC’s Institutional Biosafety Committee (IBC) ensures the health and safety of all personnel working with biohazardous agents on the premises of the University of Nebraska Medical Center and UNO.
In accordance with NIH Guidelines for Research Involving Recombinant DNA Molecules and the Select Agent Rule, the IBC plans and implements the campus Biosafety Program, drafts campus biosafety policies and procedures, and reviews individual research proposals for biosafety concerns.
During proposal review, a sponsor will ask for documentation of IBC approval. Also, before award set-up and during the project period, SPAdmin links projects to IBC protocols and monitors the status. A PI cannot work with biohazardous agents without an active IACUC protocol.